로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > CD5 > RES-A031

resDetect™ Human CD5 ELISA Kit (Residue Testing)

For research use only.

Order Now

    Product Specifications
    Assay TypeSandwich-ELISA
    AnalyteCD5
    Format96T (8×12 strips)
    ReactivityHuman
    Regulatory StatusRUO
    Sensitivity<20 pg/mL
    Standard Curve Range20 pg/mL-1280 pg/mL
    Assay Time2 hr 20 min
    Suitable Sample TypeFor the detection and quantitative determination of CD5 in cell culture supernates.
    Sample volume100 μL
  • Product Overview
    resDetect™ Human CD5 ELISA Kit (Residue Testing) is based on the Sandwich-ELISA method and is used to detect and quantitatively determine human CD5 antibody residues cell culture supernates. It is designed to provide a reliable solution for cell therapy product quality assessment during drug development and CMC quality control stages.
  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

    Materials Provided
    IDComponentsSize
    RES031-C01Pre-coated Anti-CD5 Antibody Microplate1 plate (8×12 strips)
    RES031-C02Human CD5 Standard20 μg
    RES031-C03Biotin-Anti-CD5 Antibody15 μg
    RES031-C04Streptavidin-HRP10 μg
    RES031-C0520xWashing Buffer50 mL
    RES031-C06Dilution Buffer50 mL
    RES031-C07Substrate Solution12 mL
    RES031-C08Stop Solution7 mL
Typical Data Please refer to DS document for the assay protocol.
 CD5 TYPICAL DATA

For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

  • Clinical and Translational Updates

Comments (0)

Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:6 Details
  • Latest Research Phase:Phase 2 Clinical

Datasheet & Documentation

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop